Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Fine for single-use applications
The COR-II trial, conducted in participants with diabetes, showed 5.0% weight loss compared to 1.8% with placebo
However, some patients experience increased perspiration indirectly through low blood sugar or dehydration
Image shown does not include required overpatch
Improved glycaemic control : In individuals with type 2 diabetes, semaglutide enhances insulin secretion in a glucose-dependent manner and suppresses inappropriate glucagon release
US$ 22.65
US$ 22.60
US$ 25.83
US$ 22.66
US$ 28.52
US$ 25.91
US$ 27.77
